BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36148537)

  • 1. Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID-19: A meta-analysis.
    Aziz MA; Islam MS
    Mol Genet Genomic Med; 2022 Nov; 10(11):e2063. PubMed ID: 36148537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants.
    Sheikhian F; Sadeghi Mofrad S; Tarashi S; Ghazanfari Jajin M; Sakhaee F; Ahmadi I; Anvari E; Sheikhpour M; Fateh A
    Hum Genomics; 2023 Jun; 17(1):54. PubMed ID: 37328914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
    Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
    Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
    Pecoraro V; Cuccorese M; Trenti T
    Clin Exp Med; 2023 Nov; 23(7):3251-3264. PubMed ID: 37055652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Nucleotide Variants (SNVs) of Angiotensin-Converting Enzymes (ACE1 and ACE2): A Plausible Explanation for the Global Variation in COVID-19 Prevalence.
    Atiku SM; Kasozi D; Campbell K
    J Renin Angiotensin Aldosterone Syst; 2023; 2023():9668008. PubMed ID: 37051471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease.
    Alimoradi N; Sharqi M; Firouzabadi D; Sadeghi MM; Moezzi MI; Firouzabadi N
    Virol J; 2022 Mar; 19(1):48. PubMed ID: 35305693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis.
    Keikha M; Karbalaei M
    Microb Pathog; 2022 Nov; 172():105781. PubMed ID: 36116608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease.
    Najafi M; Mahdavi MR
    Mol Genet Genomics; 2023 Jan; 298(1):27-36. PubMed ID: 36255490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
    Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
    J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels.
    Beyranvand S; Davoodian P; Alizade H; Gouklani H; Nejatizadeh A; Eftekhar E; Nikpoor AR
    Cell Biol Int; 2023 Apr; 47(4):731-741. PubMed ID: 36511187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
    Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
    Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
    Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
    Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Martínez-Gómez LE; Herrera-López B; Martinez-Armenta C; Ortega-Peña S; Camacho-Rea MDC; Suarez-Ahedo C; Vázquez-Cárdenas P; Vargas-Alarcón G; Rojas-Velasco G; Fragoso JM; Vidal-Vázquez P; Ramírez-Hinojosa JP; Rodríguez-Sánchez Y; Barrón-Díaz D; Moreno ML; Martínez-Ruiz FJ; Zayago-Angeles DM; Mata-Miranda MM; Vázquez-Zapién GJ; Martínez-Cuazitl A; Barajas-Galicia E; Bustamante-Silva L; Zazueta-Arroyo D; Rodríguez-Pérez JM; Hernández-González O; Coronado-Zarco R; Lucas-Tenorio V; Franco-Cendejas R; López-Jácome LE; Vázquez-Juárez RC; Magaña JJ; Cruz-Ramos M; Granados J; Hernández-Doño S; Delgado-Saldivar D; Ramos-Tavera L; Coronado-Zarco I; Guajardo-Salinas G; Muñoz-Valle JF; Pineda C; Martínez-Nava GA; López-Reyes A
    Front Immunol; 2022; 13():812940. PubMed ID: 35250987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population.
    Khalilzadeh F; Sakhaee F; Sotoodehnejadnematalahi F; Zamani MS; Ahmadi I; Anvari E; Fateh A
    Int J Immunogenet; 2022 Oct; 49(5):325-332. PubMed ID: 36029284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients.
    Akbari M; Taheri M; Mehrpoor G; Eslami S; Hussen BM; Ghafouri-Fard S; Arefian N
    Vascul Pharmacol; 2022 Feb; 142():106934. PubMed ID: 34774774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
    Sabater Molina M; Nicolás Rocamora E; Bendicho AI; Vázquez EG; Zorio E; Rodriguez FD; Gil Ortuño C; Rodríguez AI; Sánchez-López AJ; Jara Rubio R; Moreno-Docón A; Marcos PJ; García Pavía P; Villa RB; Gimeno Blanes JR
    PLoS One; 2022; 17(2):e0263140. PubMed ID: 35120165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of
    Dobrijevic Z; Robajac D; Gligorijevic N; Šunderic M; Penezic A; Miljuš G; Nedic O
    EXCLI J; 2022; 21():818-839. PubMed ID: 35949487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A single-center cohort study.
    Baştuğ S; Çavdarlı B; Baştuğ A; Şencan İ; Tunçez E; Yakışık Çakır E; Kemirtlek N; Sakar C; Erdem D; Güleç Ceylan G; Özkoçak Turan I; Kazancıoğlu S; Bodur H
    Anatol J Cardiol; 2022 Feb; 26(2):133-140. PubMed ID: 35190362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study.
    Sienko J; Marczak I; Kotowski M; Bogacz A; Tejchman K; Sienko M; Kotfis K
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?
    Yamamoto N; Yamamoto R; Ariumi Y; Mizokami M; Shimotohno K; Yoshikura H
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.